- Home
- RFIL vs LPCN Comparison
RFIL vs LPCN Comparison
Compare RFIL & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- LPCN
- Stock Information
- Founded
- RFIL 1979
- LPCN 1997
- Country
- RFIL United States
- LPCN United States
- Employees
- RFIL N/A
- LPCN N/A
- Industry
- RFIL Electrical Products
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- LPCN Health Care
- Exchange
- RFIL Nasdaq
- LPCN Nasdaq
- Market Cap
- RFIL 44.7M
- LPCN 16.1M
- IPO Year
- RFIL N/A
- LPCN N/A
- Fundamental
- Price
- RFIL $5.65
- LPCN $3.29
- Analyst Decision
- RFIL Strong Buy
- LPCN Strong Buy
- Analyst Count
- RFIL 1
- LPCN 2
- Target Price
- RFIL $4.50
- LPCN $9.00
- AVG Volume (30 Days)
- RFIL 98.7K
- LPCN 61.0K
- Earning Date
- RFIL 06-16-2025
- LPCN 08-07-2025
- Dividend Yield
- RFIL N/A
- LPCN N/A
- EPS Growth
- RFIL N/A
- LPCN N/A
- EPS
- RFIL N/A
- LPCN N/A
- Revenue
- RFIL $73,399,000.00
- LPCN $3,674,834.00
- Revenue This Year
- RFIL $16.16
- LPCN N/A
- Revenue Next Year
- RFIL $9.55
- LPCN N/A
- P/E Ratio
- RFIL N/A
- LPCN N/A
- Revenue Growth
- RFIL 20.14
- LPCN N/A
- 52 Week Low
- RFIL $3.27
- LPCN $2.68
- 52 Week High
- RFIL $6.54
- LPCN $8.71
- Technical
- Relative Strength Index (RSI)
- RFIL 76.51
- LPCN 51.52
- Support Level
- RFIL $4.08
- LPCN $3.13
- Resistance Level
- RFIL $5.84
- LPCN $3.53
- Average True Range (ATR)
- RFIL 0.34
- LPCN 0.24
- MACD
- RFIL 0.14
- LPCN 0.01
- Stochastic Oscillator
- RFIL 89.78
- LPCN 48.33
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.